Study Title
Comparison of the Detection Efficiencies of Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT in Patients With Prostate Cancer
Study Details
Description:
18F-labeled prostate-specific membrane antigen (PSMA) ligand-positron emission tomography (PET) offers advantages over 68Ga-labeled PSMA ligands. Al18F-PSMA-617 is a novel 18F-PSMA compound used for prostate cancer (PCa) imaging. This pilot study was prospectively designed to compare the lesion detectability of Al18F-PSMA-617 and related 68Ga-PSMA-617 PET/CT in patients with PCa
Contacts:
Li Huo, MDhuoli@pumch.cn
86-13910801986
Guilan Hu, MDherb515@sina.com
86-18701023071
Government Study Link:
NCT05841992 - Click here to see study onClinicalTrials.gov